Bluminate helps to prevent hospital-acquired infections
Bluminate (formerly VAPGuard) is transforming infection prevention in critical care with a novel, patent-pending medical device that reduces the risk of the most costly and deadly hospital-acquired infections, such as ventilator-associated pneumonia and catheter-associated urinary tract infections.
read more









